Ro 61-8048, kynurenine 3-monooxygenase (KMO) inhibitor (ab141466)
Key features and details
- Potent, competitive kynurenine 3-monooxygenase (KMO) inhibitor
- CAS Number: 199666-03-0
- Purity: > 98%
- Soluble in DMSO to 100 mM and in ethanol to 10 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Ro 61-8048, kynurenine 3-monooxygenase (KMO) inhibitor -
Description
Potent, competitive kynurenine 3-monooxygenase (KMO) inhibitor -
Purity
> 98% -
General notes
This product is manufactured by BioVision, an Abcam company and was previously called 1912 Ro 61-8048. 1912-25 is the same size as the 25 mg size of ab141466.
-
CAS Number
199666-03-0 -
Chemical structure
Properties
-
Chemical name
3,4-Dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide -
Molecular weight
421.45 -
Molecular formula
C17H15N3O6S2 -
PubChem identifier
5282337 -
Storage instructions
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in DMSO to 100 mM and in ethanol to 10 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
COC1=C(C=C(C=C1)S(=O)(=O)NC2=NC(=CS2)C3=CC(=CC=C3)[N+](=O)[O-])OC -
Source
Synthetic
-
Research areas
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab141466 has not yet been referenced specifically in any publications.